Ategra Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-12,342
| Closed | -$669K | – | 32 |
|
2024
Q1 | $669K | Sell |
12,342
-4,500
| -27% | -$244K | 0.3% | 49 |
|
2023
Q4 | $864K | Sell |
16,842
-3,363
| -17% | -$173K | 0.38% | 44 |
|
2023
Q3 | $1.17M | Sell |
20,205
-914
| -4% | -$53K | 0.64% | 38 |
|
2023
Q2 | $1.35M | Buy |
21,119
+1,780
| +9% | +$114K | 0.73% | 34 |
|
2023
Q1 | $1.34M | Buy |
19,339
+1,560
| +9% | +$108K | 0.74% | 36 |
|
2022
Q4 | $1.28M | Buy |
17,779
+1,143
| +7% | +$82.2K | 0.65% | 33 |
|
2022
Q3 | $1.18M | Sell |
16,636
-357
| -2% | -$25.4K | 0.61% | 36 |
|
2022
Q2 | $1.31M | Buy |
16,993
+171
| +1% | +$13.2K | 0.67% | 39 |
|
2022
Q1 | $1.23M | Sell |
16,822
-269
| -2% | -$19.6K | 0.54% | 43 |
|
2021
Q4 | $1.07M | Sell |
17,091
-196
| -1% | -$12.2K | 0.46% | 47 |
|
2021
Q3 | $1.02M | Buy |
17,287
+1
| +0% | +$59 | 0.49% | 46 |
|
2021
Q2 | $1.16M | Sell |
17,286
-106
| -0.6% | -$7.08K | 0.56% | 42 |
|
2021
Q1 | $1.1M | Buy |
17,392
+163
| +0.9% | +$10.3K | 0.61% | 38 |
|
2020
Q4 | $1.07M | Sell |
17,229
-1,384
| -7% | -$85.9K | 0.74% | 31 |
|
2020
Q3 | $1.12M | Sell |
18,613
-551
| -3% | -$33.2K | 1% | 29 |
|
2020
Q2 | $1.13M | Buy |
19,164
+45
| +0.2% | +$2.65K | 1.08% | 24 |
|
2020
Q1 | $1.07M | Sell |
19,119
-125
| -0.6% | -$6.97K | 1.25% | 20 |
|
2019
Q4 | $1.24M | Hold |
19,244
| – | – | 1.04% | 21 |
|
2019
Q3 | $976K | Sell |
19,244
-1,136
| -6% | -$57.6K | 0.89% | 24 |
|
2019
Q2 | $924K | Sell |
20,380
-3,283
| -14% | -$149K | 0.87% | 26 |
|
2019
Q1 | $1.13M | Buy |
+23,663
| New | +$1.13M | 1.1% | 18 |
|